| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 48,221 | 86,142 | 51,714 | 72,706 | | Cost of Revenue | (665) | (145,992) | 146,657 | 175,786 | | | Gross Profit | 48,886 | 232,134 | (94,943) | (103,080) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 161,940 | 344,012 | 22,317 | 30,933 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,001 | 833 |
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (114,055) | (112,711) | (117,260) | (134,013) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,225 | 106,235 | (20,860) | 2,174 | | Earnings Before Interest And Taxes | (112,830) | (6,476) | (138,120) | (131,839) | | Interest Expense | 3,051 | 3,620 | 2,947 | 6,677 | | Income Before Tax | (115,881) | (10,096) | (141,067) | (138,516) | | Income Tax Expense | (1,300) | 1,934 | 618 | 1,575 | | Minority Interest | 26,781 | 9,080 |
-
| (2,567) | | | | Net Income From Continuing Ops | (2,979) | (2,950) | (141,685) | (142,658) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (123,661) | (2,950) | (141,685) | (142,658) | | Preferred Stock And Other Adjustments |
-
| (21,426) | 21,426 |
-
| | | Net Income Applicable To Common Shares | ($99,018) | ($24,376) | ($120,259) | ($142,658) |
|
0.51% Nasdaq 0.00%
Income Statement
